2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




TVA Medical’s everlinQ endoAVF System Receives Additional Reimbursement in Germany

February 10, 2016 -- TVA Medical, Inc. announced that its everlinQ endoAVF system, which is designed to create an arteriovenous fistula for hemodialysis using an endovascular …

Study Shows Benefits of IVUS During Lower Limb Endovascular Interventions

February 10, 2016 -- Findings from a study conducted to examine the impact of intravascular ultrasound (IVUS) utilization during lower limb endovascular interventions, in rega…

CSI’s LIBERTY 360° Demographic Data Presented at ISET

February 10, 2016 -- Cardiovascular Systems, Inc. (CSI) announced that key baseline demographic data from its LIBERTY 360° postmarket study were presented by Jihad Mustaph…

Stentys’s Self-Apposing, Self-Expanding DES for BTK Launched in Europe

February 8, 2016 -- Stentys announced the initiation of commercialization of the company’s self-apposing, self-expanding paclitaxel-eluting stent for a below-the-knee (B…

First Patient Treated in Study of Medtronic Valiant TAAA Stent Graft System

February 9, 2016 -- Medtronic plc and Sanford Health, one of the nation’s largest health care systems, announced the first patient enrolled in a clinical study using the…

Merit Medical Acquires the Hero Graft From CryoLife

February 4, 2016 -- Merit Medical Systems, Inc. announced that it has purchased the Hero Graft device and related assets from CryoLife, Inc. for $18.5 million. The Hero Graft …

Lombard’s Altura EVAR Device Launched in Europe

February 4, 2016 -- Lombard Medical, Inc. announced the first commercial procedure using the Altura endovascular stent graft for the endovascular aneurysm repair (EVAR) of abd…

Click here for more News coverage

Current Supplement


Clearing the Clot

Moving Beyond Standard DVT Treatment

Current European Supplement

Sponsored by Cook Medical

Global Approaches to Type B Dissection

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $36.62  -1.59%
AstraZeneca PLC $29.19  0.52%
Boston Scientific Corporation $16.58  -2.01%
BTG plc $572.00  -1.21%
Cardinal Health $77.42  -1.02%
Cardiovascular Systems Inc. $8.46  -1.63%
CR Bard Inc. $183.72  -1.31%
Edwards Lifesciences Corp. $77.47  -1.94%
Endologix Inc. $6.81  -3.95%
Hansen Medical, Inc. $2.17  -1.36%
Vascular Market Price  Change
Johnson and Johnson $100.07  -1.63%
Lombard Medical, Inc. $0.65  -2.27%
Medtronic, Inc. $72.99  -1.58%
Merit Medical Systems, Inc. $16.19  -0.98%
St. Jude Medical Inc. $49.60  -2.21%
The Medicines Company $28.48  -1.89%
The Spectranetics Corporation $11.99  -0.91%
TriVascular Technologies, Inc. $5.87  0.00%
Vascular Solutions Inc. $25.25  -1.14%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media